FDA Inspection 1167882 — Soo Aleman, MD

Soo Aleman, MD — FEI 3021335565

The FDA completed an inspection of Soo Aleman, MD on March 31, 2022 in Stockholm. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 31, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Stockholm (Sweden)

Additional Details

Clinical Investigator (CI)